Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > Aptosyn

Aptosyn (exisulind) : Cell Pathways : Antineoplastic agent

Aptosyn (exisulind) - Recent MEDLINE Abstracts (PubMed)

Aptosyn Clinical Trials (ClinicalTrials.gov)


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 26-Apr-2011
Karen Parles, MLS Editor